Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,124 | -37,720 | -21,558 | -4,478 | -17,680 |
| Depreciation Amortization | 232 | 54 | 33 | 26 | 91 |
| Accounts payable and accrued liabilities | 669 | 4 | -177 | 173 | N/A |
| Other Working Capital | -876 | -2,937 | -2,005 | -1,626 | 1,774 |
| Other Operating Activity | 13,881 | 23,619 | 13,621 | 278 | 6,744 |
| Operating Cash Flow | $-22,218 | $-16,980 | $-10,086 | $-5,627 | $-9,071 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,835 | -1,331 | -939 | -229 | -1,476 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 39,931 |
| Investing Cash Flow | $-1,835 | $-1,331 | $-939 | $-229 | $38,455 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 71,800 | 71,800 | 445 | 112 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 490 |
| Financing Cash Flow | $71,800 | $71,800 | $445 | $112 | $490 |
| Beginning Cash Position | 35,319 | 35,319 | 35,319 | 35,319 | 5,445 |
| End Cash Position | 83,066 | 88,808 | 24,739 | 29,575 | 35,319 |
| Net Cash Flow | $47,747 | $53,489 | $-10,580 | $-5,744 | $29,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,218 | -16,980 | -10,086 | -5,627 | -9,071 |
| Capital Expenditure | -1,835 | -1,331 | -939 | -229 | N/A |
| Free Cash Flow | -24,053 | -18,311 | -11,025 | -5,856 | -9,071 |